David Shaw’s Melinta Therapeutics, Inc. Common Stock MLNT Stock Holding History

David Shaw’s Portfolio MLNT Stock Details MLNT Fund Activity

Bought

Maintained

Sold

Quarter	Market Value	Status	Shares	Change in Stake	Trade Value	Portfolio Weight	Portfolio Position
2020 Q1	–	Sell	-14,335	Closed	-$8K	–	4470
2019 Q4	$8K	Buy	+14,335	New	+$34.8K	﹤0.01%	3924
2019 Q3	–	Sell	-53,672	Closed	-$357K	–	4130
2019 Q2	$357K	Buy	+53,672	New	+$204K	﹤0.01%	3238

David Shaw's MLNT Position: Q1 2020 in Review

David Shaw sold out of Melinta Therapeutics, Inc. Common Stock (MLNT) in Q1 2020, closing a stake of 14,335 shares — an estimated $8K sold.

David Shaw first reported a position in MLNT in Q2 2019 and held it in 2 quarters. The position peaked at $357K in Q2 2019. 2 funds tracked by Wall St. Rank hold MLNT as of Q1 2020.

David Shaw reported no remaining Melinta Therapeutics, Inc. Common Stock position as of Q1 2020 after selling out during the quarter.
David Shaw sold 14,335 Melinta Therapeutics, Inc. Common Stock shares in Q1 2020, an estimated $8K.
David Shaw first reported a position in Melinta Therapeutics, Inc. Common Stock in Q2 2019 and held it in 2 quarters.
David Shaw's Melinta Therapeutics, Inc. Common Stock position peaked at $357K in Q2 2019.
2 funds tracked by Wall St. Rank held Melinta Therapeutics, Inc. Common Stock as of Q1 2020.

Based on D.E. Shaw & Co's 13F filing for Q1 2020, filed 15 May 2020.